Dr Gerstenfeld is the Melvin Scheinman Endowed Professor of Medicine and Chief of the Section of Cardiac Electrophysiology at UCSF. He is the Associate Editor of the Journal of Cardiac Electrophsyiology, is on the editorial board of multiple Cardiology/EP journals, has served 7 years on the ABIM CCEP board writing committee and the 2017 HRS/EHRA/ECAS/APHRS guideline committee for catheter and surgical ablation of atrial fibrillation.

CLINICAL INTERESTS:
1) Treatment of atrial fibrillation (including catheter ablation of paroxysmal and persistent AF); mapping and ablation of atrial tachycardias/flutters that occur after AF ablation;
2) Treatment and ablation of supraventricular tachycardias (atrial tachycardia, atrial flutter, AV node reentry, Wolff-Parkinson-White syndrome);
3) Mapping and ablation of ventricular tachycardia in patients with normal hearts, ischemic and nonischemic cardiomyopathy (including epicardial mapping and ablation).
4) Treatment of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVC), including endocardial and epicardial mapping.
5) Treatment of patients with inherited arrhythmia syndromes including long QT syndrome (LQTS), catecholaminergic VT (CPVT), Brugada syndrome, hypertrophic cardiomyopathy

RESEARCH INTERESTS:
Dr Gerstenfeld's laboratory is interested in better understanding the mechanism of atrial fibrillation using signal processing an humans and preclinical models studying differences between endocardial and epicardial activation during AF. Dr Gerstenfeld's laboratory has one of the only preclinical swine models of pacing induced cardiomyopathy and seeks to better understand the mechanism of cardiomyopathy causes by premature ventricular beats. He also has performed preclinical work to improve ablation techniques for ventricular tachycardia, including hi intensity ultrasound (HiFU) and multipolar linear ablation.